杨华;王述进;左红;马磊. 脂代谢指标、血清hs-CRP水平在2型糖尿病亚临床甲状腺功能减退患者中的表达及其意义[J]. 医学临床研究, 2017, 34(12): 2312-2315,2317.
YANG Hua, WANG Shu-jin, ZUO Hong,et al. Significance of Lipid Metabolism and Serum hs-CRP Levels in Patients with Subclinical Hypothyroidism of Type 2 Diabetes Mellitus. JOURNAL OF CLINICAL RESEARCH, 2017, 34(12): 2312-2315,2317.
[1] Palma CC, Pavesi M, Nogueira VG,et al. Prevalence of thyroid dysfunction in patients with diabetes mellitus[J].Diabetol Metab Syndr,2013,5(1):58. [2] 李子振, 王镁. 2型糖尿病合并亚临床甲状腺功能减退症116例临床分析[J].中国当代医药, 2016, 23(2):29-32. [3] 侯扬, 杨静. 2型糖尿病合并亚临床甲状腺功能减退症的研究进展[J].中国药物与临床, 2015, 15(05):656-659. [4] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J].中华内分泌代谢杂志, 2014, 30(10):26-89. [5] Baskin HJ, Cobin RH, Duick DS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism[J].Endocr Pract,2002,8(6):457-469. [6] Han C, He X, Xia X, et al. Subclinical hypothyroidism and type 2 diabetes: a systematic review and meta-analysis[J].PLoS One,2015, 10(8):e0135233. [7] 赵继霞. 老年亚临床甲状腺功能减退症患者应用甲状腺素对其血脂、血糖、血尿酸水平的影响[J].中国实用医药, 2016, 11(33):100-102. [8] 陈晓蕾, 田林玉, 张建伟,等. 2型糖尿病合并亚临床甲状腺功能减退的临床特征[J].中国糖尿病杂志, 2016, 24(10):923-927. [9] 蒋秋明, 张熙洋, 雷蕾. 亚临床甲状腺功能减退对糖尿病患者血糖、血脂、尿酸代谢的影响[J].中国医药导报, 2016, 13(18):80-84. [10] atlι G, Anιk A, Tuhan H, et al. The Effect of l-thyroxine treatment on hypothyroid symptom scores and lipid profile in children with subclinical hypothyroidism[J].J Clin Res Pediatr Endocrinol,2014, 6(4):238-244. [11] 靳丽娟, 兰丽珍, 刘小琪. 亚临床甲状腺功能减退与2型糖尿病病人微血管并发症的相关性研究[J].中西医结合心脑血管病杂志, 2014,2(4):425-427. [12] 杨灿.血清超敏 C-反应蛋白水平在2型糖尿病患者并发动脉粥样硬化监测中的应用[J].吉林医学, 2017, 38(2):313. (本文编辑:邓丽萍) [收稿日期] 2017-09-28
2017, Vol. 34 
